Author

Nathan J Wellington

University of the Sunshine CoastORCID 0000-0002-4980-0346Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:DNA methylation· 1

Frequent Co-Authors

Ana Paula BouçasiD· 2 shared Anna KuballaiD· 2 shared Bonnie L. QuigleyiD· 2 shared Jim LagopoulosiD· 2 shared Adem CaniD· 1 shared Megan DuttoniD· 1 shared Paul SchwenniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

7 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Ana Paula BouçasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Temporal Immune Effects of Oral Ketamine on PTSD: Transcriptomic Evidence of Short-Term Inflammation Suppression and Long-Term Immune Remodelling

Nathan J Wellington, Bonnie L. Quigley, Ana Paula Bouças, Megan Dutton, Adem Can, Jim Lagopoulos, Anna Kuballa

This study examines the short- and long-term transcriptomic effects of oral ketamine on PTSD, revealing inflammation suppression and immune remodelling through gene expression analysis.

medRxiv · May 26, 2025 · PreprintGenetic & Genomic Medicine

Methylome and transcriptome functional analysis identifies key biomarkers in ketamine's sustained therapeutic effect on PTSD

Nathan J Wellington, Ana Paula Bouças, Paul Schwenn, Jim Lagopoulos, Bonnie L. Quigley, Anna Kuballa

This study identifies key methylomic and transcriptomic biomarkers predictive of sustained ketamine response in PTSD by comparing responders and non-responders.

medRxiv · May 25, 2025 · PreprintGenetic & Genomic Medicine